Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HRNR Antibody | Login | HRNR Antibody | ||||||||||||||||
|
||||||||||||||||||
| TXNRD1 Antibody | Login | TXNRD1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CNN1 Antibody | Login | CNN1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| PRKAA1 Antibody | Login | PRKAA1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| UGT2B15 Antibody | Login | UGT2B15 Antibody | ||||||||||||||||
|
||||||||||||||||||
| P70 S6K Antibody | Login | P70 S6K Antibody | ||||||||||||||||
|
||||||||||||||||||
| NOTCH1 Antibody | Login | NOTCH1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| Fibronectin Antibody | Login | Fibronectin Antibody | ||||||||||||||||
|
||||||||||||||||||
| LMNB1 Antibody | Login | LMNB1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ERK1 / ERK2 Antibody | Login | ERK1 / ERK2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CDKL3 Antibody | Login | CDKL3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| FCN2 Antibody | Login | FCN2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| KISS1 Antibody | Login | KISS1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CD70 Antibody | Login | CD70 Antibody | ||||||||||||||||
|
||||||||||||||||||
| VEGFA Antibody | Login | VEGFA Antibody | ||||||||||||||||
|
||||||||||||||||||
| MARK2 Antibody | Login | MARK2 Antibody | ||||||||||||||||
|
||||||||||||||||||
| p27 KIP 1 Antibody | Login | p27 KIP 1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| GPR37 Antibody | Login | GPR37 Antibody | ||||||||||||||||
|
||||||||||||||||||
| SFRP5 Antibody | Login | SFRP5 Antibody | ||||||||||||||||
|
||||||||||||||||||
| MAPK1/MAPK3 Antibody | Login | MAPK1/MAPK3 Antibody | ||||||||||||||||
|
||||||||||||||||||
| ADARB1 Antibody | Login | ADARB1 Antibody | ||||||||||||||||
|
||||||||||||||||||
| AFP Antibody | Login | AFP Antibody | ||||||||||||||||
|
||||||||||||||||||
| XRCC4 Antibody | Login | XRCC4 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CD38 Antibody | Login | CD38 Antibody | ||||||||||||||||
|
||||||||||||||||||
| CD44 Antibody | Login | CD44 Antibody | ||||||||||||||||
|
||||||||||||||||||


